T. Rowe Price Health Sciences Fund, Inc. (PRHS.X)

Basic

  • Market Cap

    $15.01B

  • EV

    $14.94B

  • Shares Out

    172.55M

  • Revenue

    $110.74M

  • Employees

    —

Margins

  • Gross

    100%

  • EBITDA

    —

  • Operating

    -3.94%

  • Pre-Tax

    -2,502.42%

  • Net

    -2,502.42%

  • FCF

    —

Returns (5Yr Avg)

  • ROA

    0.06%

  • ROE

    17.9%

  • ROCE

    0.09%

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $0.61

  • Earnings (Dil)

    -$15.31

  • FCF

    —

  • Book Value

    $85.74

Growth (CAGR)

  • Rev 3Yr

    0.69%

  • Rev 5Yr

    5.57%

  • Rev 10Yr

    17.76%

  • Dil EPS 3Yr

    27.79%

  • Dil EPS 5Yr

    7.8%

  • Dil EPS 10Yr

    10.75%

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    -50.69%

  • DPS

    $7.76

  • DPS Growth 3Yr

    20.82%

  • DPS Growth 5Yr

    23.6%

  • DPS Growth 10Yr

    23.24%

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '12
Dec '14
Dec '16
Dec '18
Dec '20
LTM
Metric
Dec '12
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
LTM

Interest And Invest. Income

102.7

97.8

103.3

102.4

110.7

Total Revenues

102.7

97.8

103.3

102.4

110.7

Total Revenues % Chg.

17.8%

-4.8%

5.7%

-0.9%

11.0%

Gross Profit

102.7

97.8

103.3

102.4

110.7

Selling General & Admin Expenses, Total

79.6

81.6

92.6

119.3

115.1

Other Operating Expenses, Total

79.6

81.6

92.6

119.3

115.1

Operating Income

23.1

16.2

10.7

-16.9

-4.4

Currency Exchange Gains (Loss)

0.1

0.1

0.9

-0.0

-0.4

Other Non Operating Income (Expenses)

-15.7

-14.9

-15.9

-20.3

-21.1

EBT, Excl. Unusual Items

7.5

1.4

-4.4

-37.2

-25.9

Gain (Loss) On Sale Of Investments

123.8

3,231.2

4,031.8

2,336.8

-2,745.3

EBT, Incl. Unusual Items

131.3

3,232.7

4,027.4

2,299.6

-2,771.2

Earnings From Continuing Operations

131.3

3,232.7

4,027.4

2,299.6

-2,771.2

Net Income

131.3

3,232.7

4,027.4

2,299.6

-2,771.2

Net Income to Common Incl Extra Items

131.3

3,232.7

4,027.4

2,299.6

-2,771.2

Net Income to Common Excl. Extra Items

131.3

3,232.7

4,027.4

2,299.6

-2,771.2

Total Shares Outstanding

171.6

169.5

176.3

187.4

181.0

Weighted Avg. Shares Outstanding

171.6

169.5

176.3

187.4

181.0

Weighted Avg. Shares Outstanding Dil

171.6

169.5

176.3

187.4

181.0

EPS

0.8

19.1

22.8

12.3

-15.3

EPS Diluted

0.8

19.1

22.8

12.3

-15.3